Genetic variability to glp1 treatment
Conditions: Type 2 Diabetes; Obesity Interventions: Genetic: DNA Sequencing and Analysis; Genetic: differential expression analysis with RNA-sequencing (RNA seq) experiments Sponsors: GENGE Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 7, 2024 Category: Research Source Type: clinical trials
Safer Aging With Diabetes Monitoring
Conditions: Diabetes Mellitus, Type 2; Hypoglycemia Interventions: Behavioral: SAGE Group Sessions; Behavioral: SAGE Group Sessions + Diabetes Pharmacist; Other: Usual Care Sponsors: Kaiser Permanente; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Effect of Continuing Versus Holding Metformin During Hospitalizations.
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Metformin Sponsors: University of Illinois at Chicago; Emily Hanners; Dulal Bhaumik; Avisek Datta; Peggy Choye; Hailey Soni; Annesti Elmasri; Julie Jun; Colin Goodman Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
The Effect of Aromatherapy Massage on Pain, Anxiety and Comfort
Conditions: Respiratory Insufficiency; Pulmonary Disease, Chronic Obstructive; Diabetes Mellitus, Type 2; High Blood Pressure; Stroke, Ischemic Interventions: Other: Effect of aromatherapy massage on vital signs, pain, anxiety and comfort level Sponsors: Nilg ün Erdoğan Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Enhancing Digitally Delivered Diabetes Education With Real-Time CGM
Conditions: Diabetes Type 2 Interventions: Other: Dulce Digital Text Messaging Intervention; Other: CGM Device Sponsors: Scripps Whittier Diabetes Institute Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 6, 2024 Category: Research Source Type: clinical trials
Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus Interventions: Other: α-MSH infusion; Other: Placebo solutions Sponsors: Dasman Diabetes Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: ECC5004; Drug: Midazolam; Drug: Rosuvastatin; Drug: Digoxin; Drug: Atorvastatin Sponsors: Eccogene Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
To Assess With Ezefeno Tab. in Patients With Dyslipidemia and T2DM
Conditions: T2DM (Type 2 Diabetes Mellitus); Dyslipidemias Interventions: Drug: Statin and Ezefeno; Drug: Statin doubling Sponsors: Korea University Anam Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 5, 2024 Category: Research Source Type: clinical trials
A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of " BR3005 " and Co-administration of " BR3005-1 " and " BR3005-2 " Under Fasting Conditions in Healthy Adult Volunteers
Conditions: Type 2 Diabetes Mellitus Interventions: Drug: BR3005; Drug: BR3005-1; Drug: BR3005-2 Sponsors: Boryung Pharmaceutical Co., Ltd Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Renal Mechanism of SGLT2 Inhibition
Conditions: Type 2 Diabetes; Diabetic Kidney Disease Interventions: Drug: SGLT2 inhibitor Sponsors: University of Michigan; University of Colorado, Denver; Renal Pre-Competitive Consortium (RPC3) Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Efficacy and Safety of DA5221-T When Added to Ongoing DA5221-B1 and DA5221-B2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control
Conditions: Type 2 Diabetes Interventions: Drug: DA5221-T1; Drug: DA5221-T2; Drug: Placebo; Drug: DA5221-B1; Drug: DA5221-B2 Sponsors: Dong-A ST Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
BFR Walking for Insulin and Aerobic Improvement in Type 2 Diabetes
Conditions: Type 2 Diabetes Mellitus Interventions: Device: BFR Cuffs for Intervention Group; Other: Standard Walking Training Program Sponsors: Arab American University (Palestine) Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 4, 2024 Category: Research Source Type: clinical trials
Factors of Control Hypertension or Type 2 Diabetes on the Severity of Stroke and Survival Rates Within 1 Year in Trat
Conditions: Stroke; Hypertension; Type2diabetes Interventions: Other: Severity of Stroke and 1 year survival Sponsors: Phrapokklao Hospital,Thailand Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
A Study to Test How a New Long-acting Insulin Works in the Body of Patients With Type 2 Diabetes During Exercise and Prolonged Fasting
Conditions: Diabetes Mellitus, Type 2 Interventions: Drug: Insulin icodec; Drug: Insulin degludec Sponsors: Novo Nordisk A/S Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
Combining Gene Variants to Improve Risk Prediction for Metabolic (Dysfunction)- Associated Fatty Liver Disease and Its Progression to Cirrhosis in Indian Individuals With Type 2 Diabetes
Conditions: Type2diabetes Sponsors: Medanta, The Medicity, India Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2024 Category: Research Source Type: clinical trials
